Fresnais, M.; Turcan, S.; Theile, D.; Ungermann, J.; Abou Zeed, Y.; Lindner, J.R.; Breitkopf, M.; Burhenne, J.; Haefeli, W.E.; Longuespée, R.
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines 2022, 10, 1.
https://doi.org/10.3390/biomedicines10010001
AMA Style
Fresnais M, Turcan S, Theile D, Ungermann J, Abou Zeed Y, Lindner JR, Breitkopf M, Burhenne J, Haefeli WE, Longuespée R.
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines. 2022; 10(1):1.
https://doi.org/10.3390/biomedicines10010001
Chicago/Turabian Style
Fresnais, Margaux, Sevin Turcan, Dirk Theile, Johannes Ungermann, Yasmin Abou Zeed, Joshua Raoul Lindner, Marius Breitkopf, Jürgen Burhenne, Walter E. Haefeli, and Rémi Longuespée.
2022. "Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma" Biomedicines 10, no. 1: 1.
https://doi.org/10.3390/biomedicines10010001
APA Style
Fresnais, M., Turcan, S., Theile, D., Ungermann, J., Abou Zeed, Y., Lindner, J. R., Breitkopf, M., Burhenne, J., Haefeli, W. E., & Longuespée, R.
(2022). Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines, 10(1), 1.
https://doi.org/10.3390/biomedicines10010001
